Nabota 200UI

$92.90

Nabota 200UI is a type A botulinum toxin developed by Daewoong Pharmaceutical Co., Ltd. and approved by the U.S. Food and Drug Administration. As the first Korean botulinum toxin to enter the U.S. market, Nabota competes directly with Botox as a cost-effective alternative that doesn’t require changing the way you handle this potentially toxic substance.